About Allcyte
Allcyte is a company based in Vienna (Austria) founded in 2017 was acquired by Exscientia in June 2021. Allcyte has raised $6 million across 2 funding rounds from investors including Exscientia, EIT Health and 42 Capital. Allcyte operates in a competitive market with competitors including DINmotion and Drug Dosing Predictions, among others.
- Headquarter Vienna, Austria
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$6 M (USD)
in 2 rounds
-
Latest Funding Round
$6 M (USD), Seed
Mar 25, 2021
-
Investors
Exscientia
& 6 more
-
Employee Count
Not available
-
Acquired by
Exscientia
(Jun 15, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Allcyte
Allcyte has successfully raised a total of $6M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $6 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Allcyte
Allcyte has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Exscientia, EIT Health and 42 Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage technology companies are invested in across Europe.
|
Locked | Locked | Locked | |
|
Venture capital firm investing in AI & life science sectors
|
Locked | Locked | Locked | |
|
Amino Collective is engaged in backing innovative startup founders.
|
Locked | Locked | Locked |
Investor details for Allcyte
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Allcyte
Investment portfolio details for Allcyte
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Allcyte
Detailed financials for Allcyte
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Allcyte Comparisons
Peer comparison for Allcyte
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Allcyte
Allcyte operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DINmotion and Drug Dosing Predictions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Offers PBPK models and data solutions for optimizing pharmaceutical drug development processes.
|
|
| Locked | Locked | Locked |
Offers comprehensive tools for informed drug development and dosing predictions.
|
Detailed competitors of Allcyte
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Allcyte
Complete news archive for Allcyte
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Allcyte
Allcyte was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Allcyte is headquartered in Vienna, Austria.
Allcyte is a funded company, having raised a total of $6M across 2 funding rounds to date.
Developer of drugs for the treatment of cancer patients. It offers Pharmacoscopy high-content imaging platform that supports pre-clinical drug development and clinical decision making services. It enables research through the image-based quantification of single-cell phenotypes. It helps pharmaceutical companies to locate the most promising indications for their drug candidates, and doctors use it to find the correct drug for the right patients.
Allcyte's top competitors include DINmotion and Drug Dosing Predictions.
Allcyte has 7 investors. Key investors include Exscientia, EIT Health, 42 Capital, Air Street Capital, and PUSH VC.